lung cancer gene and literature database Home
Cancer metastasis database

Annotation category 5

Literatures

Literature evidence

Links to all GeneRIF Items

2073

PubMed (Gene Name)

Literature evidence

17855454 (ERCC5)

SNPs associated with prognosis of lung cancer was mapped to ERCC5.

19157633 (ERCC5)

the polymorphic status of XPG His46His was associated with susceptibility of chemotherapy in advanced non-small cell lung carcinoma

19289372 (ERCC5)

the combination of high BRCA1 and low XPG expression increases the risk of shorter survival in early non-small-cell lung cancer

23621222 (ERCC5)

polymorphisms in rs1047768 C/T and rs2296147 C/T are associated with response to platinum-based chemotherapy in advanced non-small-cell lung cancer, and XPG polymorphisms could be predictive of prognosis.

24596032 (ERCC5)

ERCC5 rs17655 polymorphism may not contribute to genetic susceptibility for lung cancer

24615519 (ERCC5)

study provided statistical evidence that XPG rs2296147T>C and rs873601G>A polymorphisms may be used as surrogate markers toward individualizing non-small cell lung cancer treatment strategies

24802942 (ERCC5)

Meta-analysis suggests that XPF Arg415Gln polymorphism may be associated with decreased lung cancer risk and XPG Asp1104His may be a low-penetrant risk factor in some cancers development.

25729984 (ERCC5)

the rs2296147 and rs2094258 polymorphisms of XPG, could be used as surrogate markers, leading to individualization of non-small cell lung cancer treatment strategies.

27323149 (ERCC5)

The results from this meta-analysis indicate that the XPG gene Asp1104His polymorphism is associated with lung cancer risk, especially in Asians.

28416771 (ERCC5)

this meta-analysis shows that XPG gene polymorphisms are associated with lung cancer and gastric cancer

30522358 (ERCC5)

XPG 2228959 C/A polymorphism contributes to protective effect in North Indian lung cancer patients. 2228959 C/A polymorphism might be associated with favorable prognosis in lung cancer risk.